Investor List:

Top Therapeutics Pre-Seed Investors in Los Angeles / Southern California (5)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Therapeutics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Brom Rector, Investor at Empath Ventures
Brom Rector
Empath Ventures·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Los Angeles (CA)
to see your intro paths to Brom
Photo of Aya Safieddine, Investor at Empath Ventures
Aya Safieddine
Empath Ventures·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Los Angeles (CA)
to see your intro paths to Aya
Photo of Eric Anschutz
Eric Anschutz
Sweet spot: $25K
Range: $10K - $250K
Investors in Boston (MA), Investors in San Francisco (CA), Investors in Shanghai, Investors in Los Angeles (CA), Investors in San Diego (CA), Investors in San Jose (CA), Investors in Oakland (CA), Investors in Emeryville (CA), Investors in Seattle (WA), Investors in British Columbia
Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Material Science (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Space (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Material Science (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Material Science (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Space (Pre-seed), Investors in BioTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Space (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Material Science (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Space (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Material Science (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Material Science (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Generative Tech/AI (Seed), Investors in Space (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in Drug Delivery (Seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in DeepTech (Seed), Investors in Drug Delivery (Seed), Investors in Material Science (Seed), Investors in Generative Tech/AI (Seed), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in Material Science (Seed), Investors in Therapeutics (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in DeepTech (Seed), Investors in Space (Seed), Investors in Diagnostics (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in Material Science (Seed), Investors in AI (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Seed), Investors in Generative Tech/AI (Seed), Investors in AI (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Seed), Investors in Generative Tech/AI (Seed), Investors in DeepTech (Seed), Investors in AI (Seed), Investors in Pharmaceuticals (Seed), Investors in Material Science (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Material Science (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Material Science (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Drug Delivery (Series A), Investors in Generative Tech/AI (Series A), Investors in Space (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Space (Series A), Investors in Generative Tech/AI (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Generative Tech/AI (Series A), Investors in DeepTech (Series A), Investors in Material Science (Series A), Investors in Generative Tech/AI (Series A), Investors in Material Science (Series A), Investors in Space (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in DeepTech (Series A), Investors in AI (Series A), Investors in Space (Series A), Investors in DeepTech (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in BioTech (Series A), Investors in Generative Tech/AI (Series A), Investors in Diagnostics (Series A), Investors in AI (Series A), Investors in Space (Series A), Investors in Generative Tech/AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in Material Science (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in Space (Series A), Investors in BioTech (Series A), Investors in DeepTech (Series A), Investors in AI (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Material Science (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Therapeutics (Series B), Investors in Drug Delivery (Series B), Investors in Material Science (Series B), Investors in Space (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in DeepTech (Series B), Investors in Therapeutics (Series B), Investors in Generative Tech/AI (Series B), Investors in Space (Series B), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in DeepTech (Series B), Investors in Material Science (Series B), Investors in Generative Tech/AI (Series B), Investors in Pharmaceuticals (Series B), Investors in Generative Tech/AI (Series B), Investors in Material Science (Series B), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Space (Series B), Investors in DeepTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Space (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in Drug Delivery (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in AI (Series B), Investors in Diagnostics (Series B), Investors in Space (Series B), Investors in Generative Tech/AI (Series B), Investors in Diagnostics (Series B), Investors in AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Space (Series B), Investors in BioTech (Series B), Investors in DeepTech (Series B), Investors in AI (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in British Columbia (Other Lists), Investors in Seattle / Portland (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)
to see your intro paths to Eric
MC
Mashuri Clark
Sweet spot: $25K
Range: $5K - $50K
Investors in SF Bay Area (CA), Investors in Denver (CO), Investors in Los Angeles (CA)
Investors in Therapeutics (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Entertainment & Sports (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Space (Pre-seed), Investors in Media/Content (Pre-seed), Investors in BioTech (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Space (Pre-seed), Investors in FinTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Entertainment & Sports (Pre-seed), Investors in SaaS (Pre-seed), Investors in BioTech (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in Entertainment & Sports (Pre-seed), Investors in Media/Content (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in Space (Pre-seed), Investors in Media/Content (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in SaaS (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in FinTech (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in BioTech (Pre-seed), Investors in Space (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in Entertainment & Sports (Pre-seed), Investors in Media/Content (Pre-seed), Investors in FinTech (Pre-seed), Investors in SaaS (Pre-seed), Investors in BioTech (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in SaaS (Pre-seed), Investors in FinTech (Pre-seed), Investors in Therapeutics (Seed), Investors in Wellness & Fitness (Seed), Investors in Entertainment & Sports (Seed), Investors in Space (Seed), Investors in Therapeutics (Seed), Investors in Web3/Crypto (Seed), Investors in Media/Content (Seed), Investors in Web3/Blockchain (Seed), Investors in BioTech (Seed), Investors in Wellness & Fitness (Seed), Investors in Space (Seed), Investors in Wellness & Fitness (Seed), Investors in FinTech (Seed), Investors in Therapeutics (Seed), Investors in Entertainment & Sports (Seed), Investors in SaaS (Seed), Investors in Media/Content (Seed), Investors in Web3/Blockchain (Seed), Investors in Entertainment & Sports (Seed), Investors in Space (Seed), Investors in Web3/Crypto (Seed), Investors in BioTech (Seed), Investors in SaaS (Seed), Investors in Therapeutics (Seed), Investors in Media/Content (Seed), Investors in FinTech (Seed), Investors in Wellness & Fitness (Seed), Investors in Space (Seed), Investors in Web3/Crypto (Seed), Investors in Web3/Blockchain (Seed), Investors in Entertainment & Sports (Seed), Investors in BioTech (Seed), Investors in SaaS (Seed), Investors in Media/Content (Seed), Investors in FinTech (Seed), Investors in Web3/Blockchain (Seed), Investors in Web3/Crypto (Seed), Investors in BioTech (Seed), Investors in SaaS (Seed), Investors in FinTech (Seed), Investors in Colorado / Utah (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)
to see your intro paths to Mashuri
Photo of Eliette Krakora, Investor
Eliette Krakora
Investor
Sweet spot: $100K
Range: $10K - $250K
Investors in Los Angeles (CA)
Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Future of Work (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Future of Work (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Drug Delivery (Seed), Investors in Therapeutics (Seed), Investors in Wellness & Fitness (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in AI (Seed), Investors in Therapeutics (Seed), Investors in Wellness & Fitness (Seed), Investors in Future of Work (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in AI (Seed), Investors in Health IT (Seed), Investors in Female Investors (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
to see your intro paths to Eliette
Get new data & insights delivered to your inbox
Firms investing in this space